“HIV‑1 drug‑resistance mutations and related risk factors among HIV‑1‑positive individuals receiving first-line antiretroviral therapy”, Univ Med, vol. 44, no. 1, pp. 57–64, Mar. 2025, doi: 10.18051/UnivMed.2025.v44.57-64.